As most Americans enter their seventh month of COVID-19-related safety measures, restlessness has given way to overthinking, and the ranks of people who identify as “vaccine hesitant” are growing quickly. This is especially true with regard to the long-promised COVID-19 vaccine. Gallup performed a poll that presented Americans with an alluring hypothetical: immediate access to…
It has been nearly eight months of social distancing and mask-wearing since the coronavirus first started spreading rapidly in the US. Initially, many states predicted that a four to six week mandatory quarantine would halt the spread of the virus and allow us to return to normalcy. However, that was far from reality. Initial forecasts…
On the eve of the 2017 World AIDS day, the Janssen Vaccines & Prevention Subdivision of Johnson & Johnson Pharmaceutical company, along with the Bill and Melinda Gates Foundation and the National Institutes of Health (NIH), announced the launch of the Imbokodo vaccine trial. The Imbokodo study will test the efficacy of a promising HIV…